{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:43:06Z","timestamp":1794980586293,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mater."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41563-025-02240-8","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:02:55Z","timestamp":1748494975000},"page":"1852-1861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-9480","authenticated-orcid":false,"given":"Sijin","family":"Luozhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1322-2676","authenticated-orcid":false,"given":"Pingchuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0156-4122","authenticated-orcid":false,"given":"Ruoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhefan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Debley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-1570","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"McIlhenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani","family":"Bhashyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Wilkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2924-6604","authenticated-orcid":false,"given":"Austin","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0603-9139","authenticated-orcid":false,"given":"Steven","family":"Lipkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9863-6899","authenticated-orcid":false,"given":"Shaoyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"2240_CR1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis, P. R. & Hope, M. J. Lipid nanoparticle systems for enabling gene therapies. Mol. Ther. 25, 1467\u20131475 (2017).","journal-title":"Mol. Ther."},{"key":"2240_CR2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/d41573-021-00110-x","volume":"20","author":"A Mullard","year":"2021","unstructured":"Mullard, A. COVID-19 vaccine success enables a bolder vision for mRNA cancer vaccines, says BioNTech CEO. Nat. Rev. Drug Discov. 20, 500\u2013501 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2240_CR3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"2240_CR4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084\u20131087 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"2240_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. Nucleic Acids 15, 1\u201311 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2240_CR6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker, L. et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int. J. Pharm. 601, 120586 (2021).","journal-title":"Int. J. Pharm."},{"key":"2240_CR7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","volume":"244","author":"P Zhang","year":"2016","unstructured":"Zhang, P., Sun, F., Liu, S. & Jiang, S. Anti-PEG antibodies in the clinic: current issues and beyond PEGylation. J. Control. Release 244, 184\u2013193 (2016).","journal-title":"J. Control. Release"},{"key":"2240_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.61","volume":"3","author":"V Kumar","year":"2014","unstructured":"Kumar, V. et al. Shielding of lipid nanoparticles for siRNA delivery: impact on physicochemical properties, cytokine induction, and efficacy. Mol. Ther. Nucleic Acids 3, e210 (2014).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2240_CR9","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","volume":"88","author":"Q Yang","year":"2016","unstructured":"Yang, Q. et al. Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population. Anal. Chem. 88, 11804\u201311812 (2016).","journal-title":"Anal. Chem."},{"key":"2240_CR10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4049\/immunohorizons.1900029","volume":"3","author":"G Besin","year":"2019","unstructured":"Besin, G. et al. Accelerated blood clearance of lipid nanoparticles entails a biphasic humoral response of B-1 followed by B-2 lymphocytes to distinct antigenic moieties. Immunohorizons 3, 282\u2013293 (2019).","journal-title":"Immunohorizons"},{"key":"2240_CR11","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304033","volume":"13","author":"A Sanchez","year":"2024","unstructured":"Sanchez, A. et al. Substituting poly(ethylene glycol) lipids with poly(2-ethyl-2-oxazoline) lipids improves lipid nanoparticle repeat dosing. Adv. Health. Mater. 13, e2304033 (2024).","journal-title":"Adv. Health. Mater."},{"key":"2240_CR12","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","volume":"16","author":"Y Ju","year":"2022","unstructured":"Ju, Y. et al. Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine. ACS Nano 16, 11769\u201311780 (2022).","journal-title":"ACS Nano"},{"key":"2240_CR13","unstructured":"Vrieze, J. Suspicions grow that nanoparticles in Pfizer\u2019s COVID-19 vaccine trigger rare allergic reactions. Science https:\/\/www.science.org\/content\/article\/suspicions-grow-nanoparticles-pfizer-s-covid-19-vaccine-trigger-rare-allergic-reactions (21 December 2020)."},{"key":"2240_CR14","first-page":"86","volume":"37","author":"DD Kang","year":"2024","unstructured":"Kang, D. D. et al. Engineering LNPs with polysarcosine lipids for mRNA delivery. Bioact. Mater. 37, 86\u201393 (2024).","journal-title":"Bioact. Mater."},{"key":"2240_CR15","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1021\/acsanm.0c01834","volume":"3","author":"SS Nogueira","year":"2020","unstructured":"Nogueira, S. S. et al. Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery. ACS Appl. Nano Mater. 3, 10634\u201310645 (2020).","journal-title":"ACS Appl. Nano Mater."},{"key":"2240_CR16","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1021\/la302433a","volume":"28","author":"Z Cao","year":"2012","unstructured":"Cao, Z., Zhang, L. & Jiang, S. Superhydrophilic zwitterionic polymers stabilize liposomes. Langmuir 28, 11625\u201311632 (2012).","journal-title":"Langmuir"},{"key":"2240_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2013.12.007","volume":"176","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Enhanced endosomal\/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA. J. Control. Release 176, 104\u2013114 (2014).","journal-title":"J. Control. Release"},{"key":"2240_CR18","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1021\/acs.chemrev.2c00344","volume":"122","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Zwitterionic biomaterials. Chem. Rev. 122, 17073\u201317154 (2022).","journal-title":"Chem. Rev."},{"key":"2240_CR19","volume":"30","author":"B Li","year":"2018","unstructured":"Li, B. et al. Zwitterionic nanocages overcome the efficacy loss of biologic drugs. Adv. Mater. 30, e1705728 (2018).","journal-title":"Adv. Mater."},{"key":"2240_CR20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nchem.1213","volume":"4","author":"AJ Keefe","year":"2011","unstructured":"Keefe, A. J. & Jiang, S. Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity. Nat. Chem. 4, 59\u201363 (2011).","journal-title":"Nat. Chem."},{"key":"2240_CR21","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1002\/anie.201808615","volume":"57","author":"B Li","year":"2018","unstructured":"Li, B. et al. Revealing the immunogenic risk of polymers. Angew. Chem. Int. Ed. 57, 13873\u201313876 (2018).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2240_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat. Protoc. 18, 265\u2013291 (2023).","journal-title":"Nat. Protoc."},{"key":"2240_CR23","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1073\/pnas.1322937111","volume":"111","author":"Y Dong","year":"2014","unstructured":"Dong, Y. et al. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc. Natl Acad. Sci. USA 111, 3955\u20133960 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2240_CR24","volume":"33","author":"ARK Kumar","year":"2021","unstructured":"Kumar, A. R. K., Shou, Y., Chan, B., L, K. & Tay, A. Materials for improving immune cell transfection. Adv. Mater. 33, e2007421 (2021).","journal-title":"Adv. Mater."},{"key":"2240_CR25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fonc.2019.00196","volume":"9","author":"S Patel","year":"2019","unstructured":"Patel, S. et al. Beyond CAR T cells: other cell-based immunotherapeutic strategies against cancer. Front. Oncol. 9, 196 (2019).","journal-title":"Front. Oncol."},{"key":"2240_CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","volume":"181","author":"EW Weber","year":"2020","unstructured":"Weber, E. W., Maus, M. V. & Mackall, C. L. The emerging landscape of immune cell therapies. Cell 181, 46\u201362 (2020).","journal-title":"Cell"},{"key":"2240_CR27","doi-asserted-by":"crossref","first-page":"1070384","DOI":"10.3389\/fmmed.2023.1070384","volume":"3","author":"F Jahan","year":"2023","unstructured":"Jahan, F. et al. Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors. Front. Mol. Med. 3, 1070384 (2023).","journal-title":"Front. Mol. Med."},{"key":"2240_CR28","volume":"14","author":"Y Chang","year":"2023","unstructured":"Chang, Y. et al. CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. Nat. Commun. 14, 2266 (2023).","journal-title":"Nat. Commun."},{"key":"2240_CR29","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1158\/1078-0432.CCR-16-1300","volume":"23","author":"J Ren","year":"2017","unstructured":"Ren, J. et al. Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition. Clin. Cancer Res. 23, 2255\u20132266 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2240_CR30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. Nat. Biotechnol. 40, 840\u2013854 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2240_CR31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.180.1.309","volume":"180","author":"S Kreiter","year":"2008","unstructured":"Kreiter, S. et al. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J. Immunol. 180, 309\u2013318 (2008).","journal-title":"J. Immunol."},{"key":"2240_CR32","doi-asserted-by":"crossref","first-page":"E3351","DOI":"10.1073\/pnas.1720542115","volume":"115","author":"M Yanez Arteta","year":"2018","unstructured":"Yanez Arteta, M. et al. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proc. Natl Acad. Sci. USA 115, E3351\u2013E3360 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2240_CR33","doi-asserted-by":"crossref","first-page":"12545","DOI":"10.1021\/acs.langmuir.0c01079","volume":"36","author":"K Aburai","year":"2020","unstructured":"Aburai, K., Hatanaka, K., Takano, S., Fujii, S. & Sakurai, K. Characterizing an siRNA-containing lipid-nanoparticle prepared by a microfluidic reactor: small-angle X-ray scattering and cryotransmission electron microscopic studies. Langmuir 36, 12545\u201312554 (2020).","journal-title":"Langmuir"},{"key":"2240_CR34","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 983 (2020).","journal-title":"Nat. Commun."},{"key":"2240_CR35","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202106727","volume":"32","author":"M Cornebise","year":"2022","unstructured":"Cornebise, M. et al. Discovery of a novel amino lipid that improves lipid nanoparticle performance through specific interactions with mRNA. Adv. Funct. Mater. 32, 2106727 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"2240_CR36","doi-asserted-by":"crossref","first-page":"18440","DOI":"10.1021\/jp303267y","volume":"116","author":"AK Leung","year":"2012","unstructured":"Leung, A. K. et al. Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core. J. Phys. Chem. C 116, 18440\u201318450 (2012).","journal-title":"J. Phys. Chem. C"},{"key":"2240_CR37","volume":"35","author":"MHY Cheng","year":"2023","unstructured":"Cheng, M. H. Y. et al. Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv. Mater. 35, e2303370 (2023).","journal-title":"Adv. Mater."},{"key":"2240_CR38","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41565-021-00928-x","volume":"16","author":"N Dammes","year":"2021","unstructured":"Dammes, N. et al. Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics. Nat. Nanotechnol. 16, 1030\u20131038 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"2240_CR39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/0300985817738095","volume":"55","author":"M Sedic","year":"2018","unstructured":"Sedic, M. et al. Safety evaluation of lipid nanoparticle-formulated modified mRNA in the Sprague-Dawley rat and cynomolgus monkey. Vet. Pathol. 55, 341\u2013354 (2018).","journal-title":"Vet. Pathol."},{"key":"2240_CR40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/biomedicines9050530","volume":"9","author":"I Vlatkovic","year":"2021","unstructured":"Vlatkovic, I. Non-immunotherapy application of LNP-mRNA: maximizing efficacy and safety. Biomedicines 9, 530 (2021).","journal-title":"Biomedicines"},{"key":"2240_CR41","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","volume":"25","author":"F Liang","year":"2017","unstructured":"Liang, F. et al. Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques. Mol. Ther. 25, 2635\u20132647 (2017).","journal-title":"Mol. Ther."},{"key":"2240_CR42","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","volume":"8","author":"N Chaudhary","year":"2024","unstructured":"Chaudhary, N. et al. Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d. Nat. Biomed. Eng 8, 1483\u20131498 (2024).","journal-title":"Nat. Biomed. Eng"},{"key":"2240_CR43","doi-asserted-by":"crossref","first-page":"e10213","DOI":"10.1002\/btm2.10213","volume":"6","author":"M Schlich","year":"2021","unstructured":"Schlich, M. et al. Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles. Bioeng Transl. Med. 6, e10213 (2021).","journal-title":"Bioeng Transl. Med."},{"key":"2240_CR44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52012","volume":"9","author":"BM Bruininks","year":"2020","unstructured":"Bruininks, B. M., Souza, P. C., Ingolfsson, H. & Marrink, S. J. A molecular view on the escape of lipoplexed DNA from the endosome. eLife 9, e52012 (2020).","journal-title":"eLife"},{"key":"2240_CR45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.nantod.2016.05.006","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu, S. & Jiang, S. Zwitterionic polymer-protein conjugates reduce polymer-specific antibody response. Nano Today 11, 285\u2013291 (2016).","journal-title":"Nano Today"},{"key":"2240_CR46","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","volume":"116","author":"JN Kochenderfer","year":"2010","unstructured":"Kochenderfer, J. N. et al. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood 116, 4099\u20134102 (2010).","journal-title":"Blood"},{"key":"2240_CR47","volume":"1","author":"JM Henderson","year":"2021","unstructured":"Henderson, J. M. et al. Cap 1 messenger RNA synthesis with co-transcriptional CleanCap\u00ae analog by in vitro transcription. Curr. Protoc. 1, e39 (2021).","journal-title":"Curr. Protoc."},{"key":"2240_CR48","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/acscentsci.1c00197","volume":"7","author":"KD Nance","year":"2021","unstructured":"Nance, K. D. & Meier, J. L. Modifications in an emergency: the role of N1-methylpseudouridine in COVID-19 vaccines. ACS Cent. Sci. 7, 748\u2013756 (2021).","journal-title":"ACS Cent. Sci."},{"key":"2240_CR49","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1107\/S1600576717011438","volume":"50","author":"JB Hopkins","year":"2017","unstructured":"Hopkins, J. B., Gillilan, R. E. & Skou, S. BioXTAS RAW: improvements to a free open-source program for small-angle X-ray scattering data reduction and analysis. J. Appl. Crystallogr. 50, 1545\u20131553 (2017).","journal-title":"J. Appl. Crystallogr."},{"key":"2240_CR50","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1021\/acs.nanolett.2c03234","volume":"22","author":"S Luozhong","year":"2022","unstructured":"Luozhong, S. et al. Phosphatidylserine lipid nanoparticles promote systemic RNA delivery to secondary lymphoid organs. Nano Lett. 22, 8304\u20138311 (2022).","journal-title":"Nano Lett."},{"key":"2240_CR51","volume":"6","author":"J Nelson","year":"2020","unstructured":"Nelson, J. et al. Impact of mRNA chemistry and manufacturing process on innate immune activation. Sci. Adv. 6, eaaz6893 (2020).","journal-title":"Sci. Adv."},{"key":"2240_CR52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","volume":"15","author":"M Baiersdorfer","year":"2019","unstructured":"Baiersdorfer, M. et al. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol. Ther. Nucleic Acids 15, 26\u201335 (2019).","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Nature Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41563-025-02240-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-025-02240-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-025-02240-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:09:04Z","timestamp":1761847744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41563-025-02240-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2240"],"URL":"https:\/\/doi.org\/10.1038\/s41563-025-02240-8","relation":{},"ISSN":["1476-1122","1476-4660"],"issn-type":[{"value":"1476-1122","type":"print"},{"value":"1476-4660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S. Luozhong, P.L., Z.Y. and S.J. are authors of a patent application related to this work (PCT\/US2021\/064639) filed by Cornell University in the United States. S. Luozhong, R. Li, P.L. and S.J. are authors of a patent related to this work (PCT\/US2024\/048135) filed by Cornell University in the United States. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}